What is immunotherapy and how is CAR T-cell therapy, a type of immunotherapy, used to treat multiple myeloma? Andrew Yee, MD, Clinical Director for the Center for Multiple Myeloma at Massachusetts, explains what multiple myeloma is, and why CAR T-cell therapy is becoming a standard treatment for this rare blood cancer.
This information in this video is provided solely for informational and educational purposes and should not be used in place of professional medical advice, diagnosis and treatment from your physician or another qualified health provider that may be available to you
Subscribe: / @massgeneralbrigham
For more information on CAR T-cell therapy for multiple myeloma: www.massgeneral.org/myelomacart
0:00 - Intro
0:14 - What is multiple myeloma?
0:20 – How was multiple myeloma treated historically?
0:34 – Immunotherapy treatments
0:55 – What is CAR T-cell therapy and how does it target multiple myeloma?
1:19 – What are the benefits of CAR T-cell therapy for multiple myeloma?
About Mass General Brigham:
Mass General Brigham combines the strength of two world-class academic medical centers, five nationally ranked specialty hospitals, 11 community hospitals, and dozens of health centers. Our doctors and researchers accelerate medical breakthroughs and drive innovations in patient care. They are leaders in medical education, serving as Harvard Medical School faculty and training the next generation of physicians. Mass General Brigham’s mission is to deliver the best, affordable health care to patients everywhere. Together, we transform the health of our communities and beyond.
#MassGeneralBrigham #MGB #Immunotherapy #CARTCellTherapy #MutipleMyeloma
Visit Mass General Brigham: www.massgeneralbrigham.org/
Find us on social:
Twitter: twitter.com/MassGenBrigham
Instagram: www.instagram.com/massgeneralbrigham/
Facebook: www.facebook.com/MassGeneralBrigham/
LinkedIn: www.linkedin.com/company/mass-general-brigham/
Mass General Brigham
コメント